Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Adamis Pharmaceuticals Corporation (ADMP)

3.81 0.01 (0.26%)

06-19 14:26

Open:

3.85

Pre. Close:

3.8

High:

3.95

Low:

3.75

Volume:

224,439

Market Cap:

127M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.004 - 4.037

4.037 - 4.059

Low:

3.685 - 3.72

3.72 - 3.743

Close:

3.755 - 3.808

3.808 - 3.844

Technical analysis  (as of: 2018-06-19 1:54:27 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 5.28     One year: 5.84

Support:

Support1: 3.75    Support2: 3.12

Resistance:

Resistance1: 4.52    Resistance2: 5.00

Pivot:

4.07

Moving Averages:

MA(5): 3.99     MA(20): 4.14

MA(100): 3.73     MA(250): 4.40

MACD:

MACD(12,26): -0.02     Signal(12,26,9): 0.03

%K %D:

%K(14,3): 17.45     %D(3): 24.31

RSI:

RSI(14): 44.56

52-Week:

High: 5.85  Low: 2.35  Change(%): -21.1

Average Vol(K):

3-Month: 42405  10-Days 28589

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ADMP has closed above bottom band by 17.4%. Bollinger Bands are 43.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADMP's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-06-19T10:57:39-04:00
Time Is Nearly Up For Adamis

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

33.39

Shares Float (M)

25.28

% Held by Insiders

% Held by Institutions

10.00

Shares Short (K)

3121

Shares Short Prior Month (K)

2190

Stock Financials

EPS

-0.660

EPS Est. Current Year

-0.750

EPS Est. Next Year

-0.330

EPS Est. Next Quarter

-0.150

Forward EPS

-0.330

Book Value (p.s.)

4.140

PEG Ratio

Profit Margin

Operating Margin

-188.88

Return on Assets (ttm)

-66.2

Return on Equity (ttm)

-95.1

Qtrly Rev. Growth

15.1

Gross Profit (p.s.)

0.096

Sales Per Share

EBITDA (p.s.)

-0.302

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.13

Levered Free Cash Flow (M)

-6.86

atoplab.com

Valuation

P/E

-5.92

P/E Growth Ratio

0.03

P/BV

0.94

P/S

283452064.00

P/CF

-8.62

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-12-13

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.